U
Gyrodyne, LLC GYRO
$5.28 -$0.19-3.39% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

Company Overview

Gyrodyne, LLC, historically associated with the publicly traded entity Gyrodyne Company of America, operates primarily as a real estate management and development company focused on medical office and mixed-use properties on Long Island, New York. The company’s activities have centered on managing, leasing, and pursuing redevelopment opportunities for legacy real estate holdings rather than operating an industrial or manufacturing business. Public filings and historical investor disclosures indicate that the company transitioned away from its earlier aviation and defense-related roots decades ago and repositioned itself around real estate asset monetization and redevelopment.

The company’s principal revenue drivers have included commercial property leasing, tenant services, and asset management activities tied to healthcare-oriented office properties and land redevelopment initiatives. Gyrodyne has historically emphasized strategic land use planning and entitlement efforts for properties in Suffolk County, New York, particularly around the Stony Brook area. Its positioning has been tied to the scarcity of developable land in parts of Long Island and proximity to healthcare, research, and university-related economic activity. Historical disclosures indicate the company evolved from a manufacturer of helicopters and related technologies into a real estate-focused enterprise following divestitures and restructuring activities completed over several decades.

Business Operations

Gyrodyne’s operations have historically revolved around two principal property assets: the Flowerfield commercial and industrial park in St. James, New York, and the Cortlandt Manor property in Westchester County, New York. Revenue generation has primarily come from leasing office, industrial, and medical-oriented commercial space to regional tenants, alongside efforts to enhance long-term land value through rezoning, planning approvals, and redevelopment initiatives. Publicly available filings indicate that the company has pursued value realization strategies through property sales, leasing optimization, and entitlement-related activities.

The company’s operations have been concentrated almost entirely within the United States, with no significant international operating footprint identified in public disclosures. Gyrodyne has historically controlled real estate assets directly rather than through a diversified operating subsidiary structure commonly seen in larger REITs or real estate conglomerates. Available public information does not indicate major international joint ventures or large-scale strategic partnerships. Data regarding current operating subsidiaries and active joint ventures is inconclusive based on available public sources.

Strategic Position & Investments

Gyrodyne’s strategic direction has historically focused on maximizing shareholder value through real estate redevelopment, property monetization, and entitlement enhancement. SEC filings and investor communications have repeatedly emphasized efforts to secure zoning approvals and redevelopment pathways that could materially increase the value of the company’s Long Island land holdings. The company has also pursued selective property sales and capital allocation measures designed to support ongoing operations and shareholder distributions where feasible.

Historically, Gyrodyne’s most significant investments have been tied to land planning, infrastructure preparation, and redevelopment-related legal and regulatory processes connected to the Flowerfield property. Public records do not indicate meaningful exposure to emerging technology sectors, venture investments, or diversified operating businesses. Unlike larger diversified real estate operators, Gyrodyne’s strategic profile has remained highly concentrated around a limited number of regional assets. Information regarding recent acquisitions or active portfolio expansion initiatives is limited, and some current strategic details are inconclusive based on available public sources.

Geographic Footprint

Gyrodyne’s operational footprint has been concentrated primarily in New York State, particularly on Long Island and in parts of the lower Hudson Valley region. The company’s headquarters and core property interests have historically been located in St. James, New York, with operations focused on regional commercial real estate markets rather than national or international expansion.

The company has not maintained a broad multinational presence or extensive cross-border investment platform according to available SEC filings and public disclosures. Its market influence has largely been tied to localized real estate development dynamics, healthcare-related tenancy, and land-use planning within the New York metropolitan region. No significant operational presence across Europe, Asia-Pacific, Latin America, or the Middle East has been identified in publicly available materials.

Leadership & Governance

Gyrodyne’s governance structure has historically reflected its relatively small scale and concentrated operational focus. Public filings identify leadership responsibilities centered on real estate management, asset monetization, financial oversight, and redevelopment execution. The company’s strategic philosophy has emphasized disciplined asset management and long-term value realization tied to land entitlements and property redevelopment opportunities.

Key executives and leadership figures identified in public disclosures include:

  • Stephen V. Maroney – President and Chief Executive Officer
  • Paul L. Lamb – Chief Financial Officer and Treasurer
  • Frederick A. Brautigan – Chairman of the Board

Historical governance records indicate that management and the board have prioritized redevelopment execution, regulatory engagement, and shareholder value realization. Some executive and governance information may have changed over time, and certain current leadership details are inconclusive based on available public sources.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $209.66
B
AAPL NASDAQ $313.45
B
AVGO NASDAQ $355.59
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $104.34
Top Financial Stocks
See All »
B
B
JPM NYSE $356.50
B
V NYSE $383.90
Top Energy Stocks
See All »
B
CVX NYSE $200.21
B
BPAQF OTC PK $7.08
Top Health Care Stocks
See All »
B
LLY NYSE $1,189.41
B
JNJ NYSE $270.00
B
ABBV NYSE $262.90
Top Real Estate Stocks
See All »
B
PLD NYSE $142.59
B
EQIX NASDAQ $1,079.61